RecruitingNot applicableNCT06160310
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Studying Tuberous sclerosis complex
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- David M. Ritter
- Principal Investigator
- David M Ritter, MD, PhDChildren's Hospital Medical Center, Cincinnati
- Enrollment
- 300 enrolled
- Eligibility
- FEMALE
- Timeline
- 2023 – 2028
Study locations (1)
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06160310 on ClinicalTrials.govOther trials for Tuberous sclerosis complex
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT06879665TANDem-2: Closing the Gap to Interventions for TANDVrije Universiteit Brussel
- RECRUITINGPHASE3NCT07403266Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)Oils4Cure
- RECRUITINGPHASE2NCT05104983Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyDarcy Krueger
- RECRUITINGNANCT06764602Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous SclerosisIRCCS Azienda Ospedaliero-Universitaria di Bologna
- ACTIVE NOT RECRUITINGNANCT04198181The Effectiveness and Safety of Resective Epilepsy Surgery for TREBeijing Children's Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT02962414Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentNovartis Pharmaceuticals
- RECRUITINGNANCT00001465Study of the Disease Process of LymphangioleiomyomatosisNational Heart, Lung, and Blood Institute (NHLBI)